Vestibular dysfunction is a manifestation of 22q11.2 deletion syndrome.
22q11 deletion syndrome
balance disorder
inner ear
labyrinth
motor development
velocardiofacial syndrome
Journal
American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
06
06
2018
revised:
08
10
2018
accepted:
27
10
2018
pubmed:
13
1
2019
medline:
17
4
2020
entrez:
13
1
2019
Statut:
ppublish
Résumé
The 22q11.2 deletion syndrome (22q11.2DS) is the second most common cause of developmental delay after Down syndrome. Impaired cognitive development is highly prevalent, but also motor abnormalities such as hypotonia and delays in achieving motor milestones are described. Instability is frequently detected in children, adolescents, and adults and is mostly attributed to their limited motor performance. Until now, vestibular function has not been investigated in these patients, despite the growing evidence that they often have inner ear malformations. The aim of this prospective study was to identify the presence and character of vestibular dysfunction in 22q11.2DS. We investigated 23 subjects with proven 22q11.2DS, older than the age of 12. We performed caloric testing and pendular rotation chair tests with videonystagmography, cervical vestibular-evoked myogenic potential (c-VEMP)-testing, and posturography. Additional otoscopy and audiometry were performed on all subjects. We found a unilateral caloric hypofunction in 55% of patients, a certain absent c-VEMP response in 15% of ears, an inconclusive c-VEMP response in 33% of ears, and abnormal posturography in 68% of patients, of whom 42% displayed a typical vestibular pattern. Remarkably, 90% revealed uni- or bilateral weak caloric responses, independent of caloric symmetry. Vestibular dysfunction is frequent in subjects with 22q11.2DS. This knowledge should be taken into account when assessing motor performance in these patients. Additional larger studies are needed to determine whether this dysfunction implicates a therapeutic potential.
Substances chimiques
T-Box Domain Proteins
0
TBX1 protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
448-454Subventions
Organisme : Fonds Wetenschappelijk Onderzoek
ID : FWO 1700317N
Pays : International
Organisme : Flanders Research Foundation
ID : FWO 1700317N
Pays : International
Informations de copyright
© 2019 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals, Inc.